Amphetamine Completed Phase 4 Trials for Eating Disorder Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT02020408Monoamine Contributions to Neurocircuitry in Eating Disorders